Charts

News

18 Jan, 2023
SOUTH SAN FRANCISCO, Calif., Jan. 18, 2023 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that from January 3, 2023, through January 17, 2023, the Compensation Committee of the Board of Directors (the “Board”) granted a new employee a stock-based award covering an aggregate of 900 shares of UNITY common stock, including options to purchase an aggregate of 900 share
10 Jan, 2023
In this article, we will discuss the 10 penny stocks that will make you a millionaire. If you want to explore similar stocks, you can also take a look at 5 Penny Stocks That Will Make You A Millionaire. Penny stocks can be an attractive option for investors looking to get in on the stock […]
02 Jan, 2023
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock increased by 149.3% to $0.5 during Monday's pre-market session. The company's market ...
30 Dec, 2022
Gainers Dermata Therapeutics (NASDAQ:DRMA) shares rose 90.5% to $0.38 during Friday's pre-market session. The market value of their ...
09 Nov, 2022
On Wednesday, 283 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Amazon.com ...
08 Nov, 2022
- Announced positive 24-week data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema; single injection led to statistically significant and clinically meaningful improvement in BCVA with favorable safety profile through six months - - 16-Week Data from Phase 2 ENVISION Study in wet Age-Related Macular Degeneration Expected in First Quarter of 2023 - - As of September 30, 2022, UNITY had approximately $103.9 million in cash, cash equivalents and marketable securities, prov
01 Nov, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unity Biotechnology (UBX) stock is gaining on Tuesday after the company released results from a Phase 2 clinical trial of UBX1325. The post Unity Biotechnology (UBX) Stock Pops on Positive Study Data appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
A single injection of UBX1325 led to a statistically significant and clinically relevant improvement in Best Corrected Visual Acuity (BCVA) of 7.6 ETDRS letters at 24 weeks compared to sham treatment UBX1325 maintained stabilization of retinal structure, as measured by central subfield thickness (CST) at 24 weeks, as compared to worsening from baseline in sham-treated patients The proportion of rescue-free patients in the UBX1325-treated arm was 59.4% at 6 months after a single injection, as com
31 Oct, 2022
Program Update with retinal expert Arshad M. Khanani, M.D., M.A., FASRS, to be held on Tuesday, November 1 at 5:00 a.m. PT/8:00 a.m. ETSOUTH SAN FRANCISCO, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it will host a program update to discuss its lead program in UBX1325 on Tuesday, November 1, 2022 at 5:00 a.m. ET/8:00 a.
20 Oct, 2022
Thursday saw 177 companies set new 52-week lows. 52-Week Low Highlights: Tesla (NASDAQ:TSLA) was the largest firm by ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another dive into the biggest pre-market stock movers as we get a start on Thursday trading with the latest news! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
19 Oct, 2022
UBX common stock expected to begin trading on a split-adjusted basis on October 20, 2022SOUTH SAN FRANCISCO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY” or the “Company”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of UNITY’s common stock. The reverse stock split will become effective at 5:00 PM Eastern Time today,
11 Oct, 2022
- Presentations from UNITY’s leadership team and fireside chat with retina expert Robert B. Bhisitkul, M.D., Ph.D., on Wednesday, October 12 from 8:00 a.m. to 9:30 a.m. ET - SOUTH SAN FRANCISCO, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, tomorrow will host an Investor and Analyst Day with presentations highlighting the UBX1325 program, a novel Bcl-xL inhibitor for
10 Oct, 2022
UNITY Biotechnology, Inc. (UBX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
07 Oct, 2022
Gainers NeuroMetrix (NASDAQ:NURO) stock moved upwards by 29.0% to $3.65 during Friday's after-market session. This security traded ...
06 Oct, 2022
-Webinar to feature presentation from retinal expert Robert B. Bhisitkul, M.D., Ph.D., on Wednesday, October 12 at 5:00 a.m. PT/8:00 a.m. ET- SOUTH SAN FRANCISCO, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it will host an Investor/Analyst Day on Wednesday, October 12, 2022 at 5:00 a.m. PT/8:00 a.m. ET to discuss the current treatment landscape
03 Oct, 2022
During Monday's session, 402 companies made new 52-week lows. Areas of Interest About Today's 52-Week ...
19 Sep, 2022
Enrollment of 51 patients exceeds target by ~10% due to high interest in the study 16-week data anticipated in Q1 2023 and 24-week data anticipated in Q2 2023 SOUTH SAN FRANCISCO, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, has completed enrollment for the ENVISION study, its Phase 2 clinical trial of UBX1325 in patients with wet age-related macular degen
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Innovative medical technology companies and anti-aging stocks are the subject of much interest on Wall Street The post The Three Best Anti-Aging Stocks to Buy in September appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
02 Sep, 2022
On Friday, 122 stocks hit new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sony Group (NYSE:SONY) ...
31 Aug, 2022
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that members of its senior management team will participate in the following investor conferences in September. Citi 17th Annual BioPharma Conference Format: One-on-one investor meetings Date: September 6 – 8, 2022Location: Four Seasons Hotel Boston, Massachusetts H.C. Wainwright 24th A
30 Aug, 2022
UNITY Biotechnology, Inc. (UBX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
19 Aug, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. Plus Therapeutics, ...
18 Aug, 2022
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 60 points on Thursday. The Dow traded down ...
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 41.6% to $0.78 during Thursday's regular session. The ...
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) ...
U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 50 points on Thursday. The Dow traded up 0.02% to ...
Gainers Plus Therapeutics (NASDAQ:PSTV) stock rose 101.5% to $1.11 during Thursday's pre-market session. The ...
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 88.7% to $1.04 in pre-market trading after the company was awarded ...
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 199.6% to close at $7.64 on Wednesday after the company announced ...
SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the pricing of an upsized underwritten public offering of 64,285,714 shares of its common stock and accompanying warrants to purchase up to 64,285,714 shares of common stock at a combined public offering price of $0.70 per share and accompanying warrant. The warrants have an ex
17 Aug, 2022
U.S. stocks pared some losses toward the end of trading, following the release of FederalReserve minutes. The Dow traded down ...
Gainers Blue Water Vaccines (NASDAQ:BWV) stock increased by 132.5% to $5.93 during Wednesday's regular session. As ...
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the ...
Unity Biotechnology Inc (NASDAQ: UBX) shares are trading lower by 19.8% to $1.10 Wednesday morning after the company announced a $25 ...
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares moved upwards by 25.7% to $6.3 during Wednesday's pre-market ...
16 Aug, 2022
SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it has commenced a proposed underwritten public offering of $25.0 million of shares of its common stock. In addition, UNITY expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the pu
Gainers IZEA Worldwide, Inc. (NASDAQ: IZEA) shares rose 30.8% to $1.19 in pre-market trading after the company reported a ...
15 Aug, 2022
Unity Biotechnology's (NASDAQ:UBX) short percent of float has risen 51.16% since its last report. The company recently ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
The U.S. index futures are seen pulling back on Monday following buoyant performances in the week ended Aug. 12. At the time of going ...
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented ...
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported ...
12 Aug, 2022
Pfizer (NYSE: PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent ...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Friday. The Dow traded ...
Gainers Unity Biotechnology (NASDAQ:UBX) stock rose 68.8% to $1.44 during Friday's regular session. Trading volume ...
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over ...
U.S. stocks extended gains midway through trading, with the Dow Jones jumping more than 250 points on Friday. The Dow traded up 0.77% ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Digital World Acquisition (DWAC) stock is sliding Friday as it seeks a vote from shareholders to extend its merger window with Truth Social. The post DWAC Stock Stumbles Ahead of Merger Extension Vote appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unity Biotechnology (UBX) stock is surging higher on Friday following the release of its earnings report for the second quarter of 2022. The post Why Is Unity Biotechnology (UBX) Stock Up 71% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
UNITY Biotechnology (NASDAQ: UBX) announced positive 12 and 18-week data from its Phase 2 BEHOLD study of UBX1325 in patients with ...
UNITY Biotechnology Inc(NASDAQ: UBX) shares are skyrocketing after12- and 18-week datafrom its Phase 2 BEHOLD study ...
- Announced Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema; single injection in subjects led to statistically significant and clinically meaningful improvement in BCVA and CST with favorable safety profile at 12 and 18 weeks - - Near-Term Milestones include 24-week Data in BEHOLD and 16-week Data in Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration by Year-End - - Tie2/VEGF Bispecific Program Achieved Advanced Candid
A single injection of UBX1325 led to a progressive, statistically significant, and clinically meaningful improvement in mean Best Corrected Visual Acuity (BCVA) at 12- and 18-weeks compared to sham treatment UBX1325 treatment also stabilized retinal structure, as measured by central subfield thickness (CST) at 12- and 18-weeks, as compared to worsening in sham-treated patients The treatment effect was seen in a patient population with visual acuity deficits and residual retinal fluid despite fre
11 Aug, 2022
Investor call with retinal expert Robert Bhisitkul, M.D., Ph.D., to be held on Friday, August 12 at 5:00 a.m. PT/8:00 a.m. ETSOUTH SAN FRANCISCO, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (Nasdaq: UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it will host an investor call to discuss lead program, UBX1325 on Friday, August 12, 2022 at 5:00 a.m. ET/8:00 a.m. ET, with retinal expert Robert Bhisitkul,
09 Aug, 2022
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. TOP Financial ...
08 Aug, 2022
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The ...
12 Jul, 2022
Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their ...
SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that 24-week clinical data results from the Phase 1 study of its lead senolytic candidate, UBX1325, in patients with diabetic macular edema and wet age-related macular degeneration will be presented at the American Society of Retina Specialists (ASRS) 40th Annual Scientific Me
10 May, 2022
10 Aug, 2021
26 Jul, 2021
11 May, 2021
08 Apr, 2021
23 Mar, 2021
16 Feb, 2021

Related Articles